These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 27124903)
21. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature. Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669 [TBL] [Abstract][Full Text] [Related]
22. Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma. Frost M; Newell J; Lones MA; Tripp SR; Cairo MS; Perkins SL Am J Clin Pathol; 2004 Mar; 121(3):384-92. PubMed ID: 15023043 [TBL] [Abstract][Full Text] [Related]
23. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205 [TBL] [Abstract][Full Text] [Related]
24. [Research advance on c-myc in aggressive B cell lymphomas]. Zhou J; Ma J Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):786-8. PubMed ID: 24447565 [No Abstract] [Full Text] [Related]
25. Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics. Turakhia SK; Hill BT; Dufresne SD; Nakashima MO; Cotta CV Am J Clin Pathol; 2014 Sep; 142(3):339-46. PubMed ID: 25125624 [TBL] [Abstract][Full Text] [Related]
26. The expression of myc and ras oncogene protein in childhood lymphomas. Sakalidou A; Kanavaros P; Tzardi M; Kalmanti M Anticancer Res; 1996; 16(1):487-91. PubMed ID: 8615659 [TBL] [Abstract][Full Text] [Related]
27. [B cell lymphoma revealed by a cranial multiple neuropathy]. Korri H; Matta C; Ali Y; Beaini M; Awada A Rev Neurol (Paris); 2009 Oct; 165(10):841-3. PubMed ID: 19733872 [No Abstract] [Full Text] [Related]
30. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas. Hernández S; Hernández L; Beà S; Cazorla M; Fernández PL; Nadal A; Muntané J; Mallofré C; Montserrat E; Cardesa A; Campo E Cancer Res; 1998 Apr; 58(8):1762-7. PubMed ID: 9563496 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome. Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208 [TBL] [Abstract][Full Text] [Related]
32. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma. Gualco G; Weiss LM; Barber GN; Bacchi CE Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409 [TBL] [Abstract][Full Text] [Related]
33. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Yu D; Thomas-Tikhonenko A Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625 [TBL] [Abstract][Full Text] [Related]
34. Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B-cell lymphomas. Brinckmann R; Kaufmann O; Reinartz B; Dietel M J Pathol; 2000 Jan; 190(1):55-60. PubMed ID: 10640992 [TBL] [Abstract][Full Text] [Related]
35. c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas. Hu F; Gartenhaus RB; Zhao XF; Fang HB; Minkove S; Poss DE; Rapoport AP Leuk Res; 2013 Apr; 37(4):447-54. PubMed ID: 23237560 [TBL] [Abstract][Full Text] [Related]
36. Expression of bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity. Takahashi H; Kawazoe K; Fujita S; Okabe H; Hideshima K; Tsuda N; Tezuka F Pathol Res Pract; 1996 Jan; 192(1):44-53. PubMed ID: 8685041 [TBL] [Abstract][Full Text] [Related]
37. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688 [TBL] [Abstract][Full Text] [Related]
38. Expression profiles of MYC protein and MYC gene rearrangement in lymphomas. Chisholm KM; Bangs CD; Bacchi CE; Molina-Kirsch H; Cherry A; Natkunam Y Am J Surg Pathol; 2015 Mar; 39(3):294-303. PubMed ID: 25581730 [TBL] [Abstract][Full Text] [Related]
39. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. Lee JT; Innes DJ; Williams ME J Clin Invest; 1989 Nov; 84(5):1454-9. PubMed ID: 2509518 [TBL] [Abstract][Full Text] [Related]
40. Primary non-Hodgkin's lymphoma of the salivary gland: a spectrum of lymphoepithelial sialadenitis, low-grade B-cell lymphoma of mucosa-associated lymphoid tissue with transformation to high-grade lymphoma. Agale SV; D'Costa GF; Hastak MS; Shedge RT Indian J Pathol Microbiol; 2010; 53(2):364-7. PubMed ID: 20551561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]